HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

SHA:600829 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	762.2	1,235	1,100	1,314	1,181	800.49
Cash & Short-Term Investments	762.2	1,235	1,100	1,314	1,181	800.49
Cash Growth	-13.02%	12.33%	-16.32%	11.25%	47.59%	91.18%
Accounts Receivable	4,502	4,086	4,350	4,385	4,168	4,182
Other Receivables	69.41	61.11	53.13	64.96	47.26	40.91
Receivables	4,571	4,147	4,403	4,450	4,215	4,222
Inventory	1,210	1,230	1,101	1,115	1,074	1,105
Prepaid Expenses	3.21	4.76	9.98	1.79	4.59	8.44
Other Current Assets	84.13	75.27	72.83	42.8	71.01	48.78
Total Current Assets	6,630	6,693	6,687	6,925	6,546	6,185
Property, Plant & Equipment	328.32	318.06	335.85	346.13	367.81	410.84
Other Intangible Assets	25.27	26.34	28.08	26.5	28.01	29.29
Long-Term Deferred Tax Assets	89.47	83.43	67.45	67.69	64.25	67.15
Long-Term Deferred Charges	7.71	8.93	10.48	11.2	11.81	12.08
Other Long-Term Assets	44.56	44.96	37.42	50.3	40.54	43.14
Total Assets	7,126	7,175	7,166	7,426	7,059	6,748

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2,665	2,836	2,781	2,914	2,614	2,478
Accrued Expenses	34.15	45.82	34.24	44.73	50.24	30.72
Short-Term Debt	706.8	679.4	839.22	962.08	1,198	1,233
Current Portion of Leases	28.24	24.89	30.56	27.69	32.09	35.18
Current Income Taxes Payable	17.55	26.96	25.84	43.33	27.38	34.92
Current Unearned Revenue	26.86	23.97	15.12	15.99	11.45	13.3
Other Current Liabilities	400.57	378.08	408.3	512.7	498.47	531.72
Total Current Liabilities	3,879	4,015	4,134	4,521	4,431	4,357
Long-Term Leases	34.85	28.08	30.37	29.41	38.48	59.59
Long-Term Unearned Revenue	111.61	113.63	117.09	120.94	125.71	130.77
Long-Term Deferred Tax Liabilities	4.46	3.31	3.7	4.05	4.51	-
Other Long-Term Liabilities	-	-	-	0.14	0.57	1.56
Total Liabilities	4,030	4,160	4,285	4,675	4,601	4,549

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	579.89	579.89	579.89	579.89	579.89	579.89
Retained Earnings	2,516	2,435	2,301	2,172	1,879	1,620
Total Common Equity	3,096	3,015	2,881	2,751	2,459	2,200
Minority Interest	-0.04	-0.04	-0.04	-0.04	-1.06	-1.02
Shareholders' Equity	3,096	3,015	2,881	2,751	2,458	2,199
Total Liabilities & Equity	7,126	7,175	7,166	7,426	7,059	6,748

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	769.89	732.37	900.15	1,019	1,268	1,328
Net Cash (Debt)	-7.7	503.04	199.69	295.17	-86.9	-527.08
Net Cash Growth	-	151.91%	-32.35%	-	-	-
Net Cash Per Share	-0.01	0.87	0.34	0.51	-0.15	-0.91
Filing Date Shares Outstanding	579.89	579.89	579.89	579.89	579.89	579.89
Total Common Shares Outstanding	579.89	579.89	579.89	579.89	579.89	579.89
Working Capital	2,752	2,678	2,553	2,404	2,115	1,829
Book Value Per Share	5.34	5.20	4.97	4.74	4.24	3.79
Tangible Book Value	3,071	2,989	2,853	2,725	2,431	2,171
Tangible Book Value Per Share	5.30	5.15	4.92	4.70	4.19	3.74
Buildings	357.93	357.93	372.04	372.04	374.91	374.93
Machinery	156.15	153.62	145.84	147.21	146.43	149.73
Construction In Progress	55.96	55.27	57.47	59.62	60.42	60.42

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error